Cargando…
Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1
PURPOSE: To determine the prevalence of choroidal abnormalities (CAs) and Lisch nodules (LNs) in children who met the clinical diagnostic criteria (CDC) alone and those with a molecularly confirmed diagnosis (MCD) of neurofibromatosis type 1 (NF1), and to ascertain any differences between the groups...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819284/ https://www.ncbi.nlm.nih.gov/pubmed/35119474 http://dx.doi.org/10.1167/tvst.11.2.10 |
_version_ | 1784646026613751808 |
---|---|
author | Flores Pimentel, Mariana Heath, Anna Wan, Michael J. Hussein, Rowaida Leahy, Kate E. MacDonald, Heather Tavares, Erika VandenHoven, Cynthia MacNeill, Katelyn Kannu, Peter Parkin, Patricia C. Heon, Elise Reginald, Arun Vincent, Ajoy |
author_facet | Flores Pimentel, Mariana Heath, Anna Wan, Michael J. Hussein, Rowaida Leahy, Kate E. MacDonald, Heather Tavares, Erika VandenHoven, Cynthia MacNeill, Katelyn Kannu, Peter Parkin, Patricia C. Heon, Elise Reginald, Arun Vincent, Ajoy |
author_sort | Flores Pimentel, Mariana |
collection | PubMed |
description | PURPOSE: To determine the prevalence of choroidal abnormalities (CAs) and Lisch nodules (LNs) in children who met the clinical diagnostic criteria (CDC) alone and those with a molecularly confirmed diagnosis (MCD) of neurofibromatosis type 1 (NF1), and to ascertain any differences between the groups. METHODS: This was a cross-sectional observational study. All children who met the CDC and/or had MCD of NF1 and underwent eye examination were included. At least two CAs or LNs between the two eyes were set as a threshold to define the presence of either abnormality. Frequencies alongside 95% confidence intervals (CIs) were calculated. The relationship between patient age and the presence of LNs and/or CAs was estimated using logistic regression. RESULTS: The study cohort included 94 patients; CAs (64%) were more prevalent than LNs (41%) (0.22; 95% CI, 0.08–0.36; P = 0.0023). The probability of the presence of LNs was lower than that of CAs across all ages (odds ratio = 0.37; 95% CI, 0.20–0.69; P = 0.00173). CAs were exclusively found in 37% of patients and LNs in 16%; 80% had either CAs or LNs, or both. In the CDC group (n = 41), the difference in prevalence (CAs = 68%, LNs = 51%) did not attain statistical significance (0.17; 95% CI, −0.06 to 0.40; P = 0.18). In the MCD group (n = 53), the difference in prevalence (CAs = 60%, LNs = 34%) was significant (0.26; 95% CI, 0.006–0.47; P = 0.023). CONCLUSIONS: CAs were more frequent than LNs in pediatric NF1 patients regardless of age and MCD status. Combining ophthalmological exams with near-infrared imaging will increase the diagnostic reach in pediatric NF1. TRANSLATIONAL RELEVANCE: CAs detected on near-infrared imaging are objective biomarkers in NF1. They are more prevalent and detected earlier in the pediatric population compared with LNs. Hence, the presence of CAs should be routinely ascertained in children suspected with NF1. |
format | Online Article Text |
id | pubmed-8819284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-88192842022-02-18 Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1 Flores Pimentel, Mariana Heath, Anna Wan, Michael J. Hussein, Rowaida Leahy, Kate E. MacDonald, Heather Tavares, Erika VandenHoven, Cynthia MacNeill, Katelyn Kannu, Peter Parkin, Patricia C. Heon, Elise Reginald, Arun Vincent, Ajoy Transl Vis Sci Technol Article PURPOSE: To determine the prevalence of choroidal abnormalities (CAs) and Lisch nodules (LNs) in children who met the clinical diagnostic criteria (CDC) alone and those with a molecularly confirmed diagnosis (MCD) of neurofibromatosis type 1 (NF1), and to ascertain any differences between the groups. METHODS: This was a cross-sectional observational study. All children who met the CDC and/or had MCD of NF1 and underwent eye examination were included. At least two CAs or LNs between the two eyes were set as a threshold to define the presence of either abnormality. Frequencies alongside 95% confidence intervals (CIs) were calculated. The relationship between patient age and the presence of LNs and/or CAs was estimated using logistic regression. RESULTS: The study cohort included 94 patients; CAs (64%) were more prevalent than LNs (41%) (0.22; 95% CI, 0.08–0.36; P = 0.0023). The probability of the presence of LNs was lower than that of CAs across all ages (odds ratio = 0.37; 95% CI, 0.20–0.69; P = 0.00173). CAs were exclusively found in 37% of patients and LNs in 16%; 80% had either CAs or LNs, or both. In the CDC group (n = 41), the difference in prevalence (CAs = 68%, LNs = 51%) did not attain statistical significance (0.17; 95% CI, −0.06 to 0.40; P = 0.18). In the MCD group (n = 53), the difference in prevalence (CAs = 60%, LNs = 34%) was significant (0.26; 95% CI, 0.006–0.47; P = 0.023). CONCLUSIONS: CAs were more frequent than LNs in pediatric NF1 patients regardless of age and MCD status. Combining ophthalmological exams with near-infrared imaging will increase the diagnostic reach in pediatric NF1. TRANSLATIONAL RELEVANCE: CAs detected on near-infrared imaging are objective biomarkers in NF1. They are more prevalent and detected earlier in the pediatric population compared with LNs. Hence, the presence of CAs should be routinely ascertained in children suspected with NF1. The Association for Research in Vision and Ophthalmology 2022-02-04 /pmc/articles/PMC8819284/ /pubmed/35119474 http://dx.doi.org/10.1167/tvst.11.2.10 Text en Copyright 2022 The Authors https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License. |
spellingShingle | Article Flores Pimentel, Mariana Heath, Anna Wan, Michael J. Hussein, Rowaida Leahy, Kate E. MacDonald, Heather Tavares, Erika VandenHoven, Cynthia MacNeill, Katelyn Kannu, Peter Parkin, Patricia C. Heon, Elise Reginald, Arun Vincent, Ajoy Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1 |
title | Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1 |
title_full | Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1 |
title_fullStr | Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1 |
title_full_unstemmed | Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1 |
title_short | Prevalence of Choroidal Abnormalities and Lisch Nodules in Children Meeting Clinical and Molecular Diagnosis of Neurofibromatosis Type 1 |
title_sort | prevalence of choroidal abnormalities and lisch nodules in children meeting clinical and molecular diagnosis of neurofibromatosis type 1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819284/ https://www.ncbi.nlm.nih.gov/pubmed/35119474 http://dx.doi.org/10.1167/tvst.11.2.10 |
work_keys_str_mv | AT florespimentelmariana prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT heathanna prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT wanmichaelj prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT husseinrowaida prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT leahykatee prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT macdonaldheather prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT tavareserika prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT vandenhovencynthia prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT macneillkatelyn prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT kannupeter prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT parkinpatriciac prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT heonelise prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT reginaldarun prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 AT vincentajoy prevalenceofchoroidalabnormalitiesandlischnodulesinchildrenmeetingclinicalandmoleculardiagnosisofneurofibromatosistype1 |